PKM1 Exerts Critical Roles in Cardiac Remodeling Under Pressure Overload in the Heart
Qinfeng Li,Chao Li,Abdallah Elnwasany,Gaurav Sharma,Yu A. An,Guangyu Zhang,Waleed M. Elhelaly,Jun Lin,Yingchao Gong,Guihao Chen,Meihui Wang,Shangang Zhao,Chongshan Dai,Charles D. Smart,Juan Liu,Xiang Luo,Yingfeng Deng,Lin Tan,Shuang-Jie Lv,Shawn M. Davidson,Jason W. Locasale,Philip L. Lorenzi,Craig R. Malloy,Thomas G. Gillette,Matthew G. Vander Heiden,Philipp E. Scherer,Luke I. Szweda,Guosheng Fu,Zhao V. Wang,Meihui Hui Wang
DOI: https://doi.org/10.1161/circulationaha.121.054885
IF: 37.8
2021-06-11
Circulation
Abstract:Background: Metabolic remodeling precedes most alterations during cardiac hypertrophic growth under hemodynamic stress. The elevation of glucose utilization has been recognized as a hallmark of metabolic remodeling. However, its role in cardiac hypertrophic growth and heart failure in response to pressure overload remains to be fully illustrated. Here, we aimed to dissect the role of cardiac PKM1 (pyruvate kinase muscle isozyme 1) in glucose metabolic regulation and cardiac response under pressure overload. Methods: Cardiac specific deletion of PKM1 was achieved by crossing the floxed PKM1 mouse model with the cardiomyocyte-specific Cre transgenic mouse. PKM1 transgenic mice were generated under the control of tetracycline response elements, and cardiac specific overexpression of PKM1 was induced by doxycycline administration in adult mice. Pressure overload was triggered by transverse aortic constriction (TAC). Primary neonatal rat ventricular myocytes were used to dissect molecular mechanisms. Moreover, metabolomics and NMR spectroscopy analyses were conducted to determine cardiac metabolic flux in response to pressure overload. Results: We found that PKM1 expression is reduced in failing human and mouse hearts. Importantly, cardiomyocyte-specific deletion of PKM1 exacerbates cardiac dysfunction and fibrosis in response to pressure overload. Inducible overexpression of PKM1 in cardiomyocytes protects the heart against TAC-induced cardiomyopathy and heart failure. At the mechanistic level, PKM1 is required for the augmentation of glycolytic flux, mitochondrial respiration, and ATP production under pressure overload. Furthermore, deficiency of PKM1 causes a defect in cardiomyocyte growth and a decrease in pyruvate dehydrogenase complex activity at both in vitro and in vivo levels. Conclusions: These findings suggest that PKM1 plays an essential role in maintaining a homeostatic response in the heart under hemodynamic stress.
cardiac & cardiovascular systems,peripheral vascular disease